↓ Skip to main content

Dove Medical Press

Post-marketing access to orphan drugs: a critical analysis of health technology assessment and reimbursement decision-making considerations

Overview of attention for article published in Orphan Drugs: Research and Reviews, January 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

policy
1 policy source
twitter
5 X users
googleplus
1 Google+ user

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
36 Mendeley
Title
Post-marketing access to orphan drugs: a critical analysis of health technology assessment and reimbursement decision-making considerations
Published in
Orphan Drugs: Research and Reviews, January 2014
DOI 10.2147/odrr.s43409
Authors

Georgi Iskrov, Rumen Stefanov

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ireland 1 3%
Unknown 35 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 31%
Researcher 6 17%
Student > Ph. D. Student 5 14%
Professor > Associate Professor 3 8%
Student > Doctoral Student 2 6%
Other 3 8%
Unknown 6 17%
Readers by discipline Count As %
Medicine and Dentistry 13 36%
Pharmacology, Toxicology and Pharmaceutical Science 6 17%
Economics, Econometrics and Finance 3 8%
Nursing and Health Professions 2 6%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 3 8%
Unknown 8 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 November 2016.
All research outputs
#4,577,218
of 25,394,764 outputs
Outputs from Orphan Drugs: Research and Reviews
#3
of 24 outputs
Outputs of similar age
#50,257
of 319,416 outputs
Outputs of similar age from Orphan Drugs: Research and Reviews
#3
of 3 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 24 research outputs from this source. They receive a mean Attention Score of 2.3. This one scored the same or higher as 21 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 319,416 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.